|4Nov 23, 6:54 PM ET

Arnold Susan Elizabeth 4

4 · PhaseBio Pharmaceuticals Inc · Filed Nov 23, 2021

Insider Transaction Report

Form 4
Period: 2021-11-19
Arnold Susan Elizabeth
VP, Preclinical and Chem.
Transactions
  • Award

    Common Stock

    2021-11-19$2.01/sh+2,559$5,14430,319 total
Footnotes (1)
  • [F1]These shares were acquired under the PhaseBio Employee Stock Purchase Plan in transactions that were exempt under both Rule 16b-3(d) and Rule 16b-3(c).

Documents

1 file
  • 4
    wf-form4_163771163783767.xmlPrimary

    FORM 4